Subscribe to Newsletter

Koen Sandra

Koen Sandra is CEO, RIC, Kortrijk, Belgium.

Content by Koen Sandra:

Fields & Applications Pharma & Biopharma

Daddy, What's the Big Deal with Antibodies?

| Koen Sandra

Koen Sandra ushers in our (bio)pharma theme for the latter half of 2020

Techniques & Tools Liquid Chromatography

The Coming of Age of 2D-LC

| Peter Schoenmakers, Bob Pirok, Koen Sandra, André de Villiers

Multidimensional LC is stepping into the spotlight - but how will it fare? Four experts share their verdicts.

Fields & Applications Professional Development

Top 40 Under 40: 4 Years On

| Sergio C. Nanita, Sebastiaan Eeltink, Kevin Schug, Koen Sandra, Rachel Louise Gomes, Helen G. Gika, Jordi Arbiol, Giorgia Purcaro, Alexander Leitner

We catch up with some of the finalists from the 40 Under 40 Power List, to find out how the award impacted their careers.

Fields & Applications Pharma & Biopharma

Specialist Snapshot: Biopharmaceutical Analysis

| Koen Sandra, Hermann Wätzig, Anurag S. Rathore

Are advances in analytical tools meeting the needs of biopharma characterization?

Fields & Applications Mass Spectrometry

Landmark Literature: Part II

| Koen Sandra, Liam Heaney, Julian Tyson, Christopher Mulligan, Vassilia Zorba

Five more analytical science experts to select a 2017 paper that stood out from the crowd

Fields & Applications Liquid Chromatography

New Wave

| Koen Sandra

Onwards and upwards - exciting new paths lie ahead for liquid chromatography

Techniques & Tools Gas Chromatography

Quo Vadis, Capillary Gas Chromatography?

| Pat Sandra, Koen Sandra, Frank David

Personal opinions on CGC based on 30 years of service to the industry.

Techniques & Tools Mass Spectrometry

The Multidimensional Future of Proteomics

| John Yates, Shabaz Mohammed, Koen Sandra, Andrea Gargano

The proteome is practically infinite in its complexity. If we are ever going to fully unravel its secrets, the best separation tools – and the best know-how – must be combined. Here, four experts discuss the broad importance of proteomics, the potential of multidimensional liquid chromatography, and the challenges inherent in gaining insight beyond the “tip of the proteo-berg.”

Fields & Applications Pharma & Biopharma

Two-dimensional Bioanalysis

| Pat Sandra, Koen Sandra, Gerd Vanhoenacker

In recent years, the top ten pharmaceuticals sales list has been extensively populated with protein therapeutics, such as monoclonal antibodies and recombinant proteins, that are used to treat various life-threatening diseases, including cancer and autoimmune diseases.

Register to The Analytical Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Analytical Scientist magazine